Home LiteratureArticle Details
PMID: 10779393 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Involvement of regions in domain I in the opioid receptor sensitivity of alpha1B Ca(2+) channels.

Molecular pharmacology ·Vol. 57 ·No. 5 ·2000-05-00 ·Pages 1064-74

Simen AA, Miller RJ

Abstract

The structural basis of Ca(2+) channel inhibition by G proteins has received considerable attention recently, and multiple regions on Ca(2+) channels that interact with G protein subunits have been identified. We have demonstrated previously that a region extending from the N terminus to the I/II loop of the Ca(2+) channel is involved in determining the differences between alpha1B and alpha1E Ca(2+) channels with respect to inhibition by G proteins. Here we explore this region of the channel in greater detail in an effort to further define the regions involved in determining inhibition. Chimeric Ca(2+) channels constructed from alpha1B and alpha1E Ca(2+) channels revealed that the N terminus, the I/II loop, and domain I all play an important role in determining inhibition. We identified a 70-amino acid fragment from domain I that mediates the effects of domain I, and a 50-amino acid fragment from the I/II loop that mediates the effects of the I/II loop. When these regions from alpha1B were exchanged into alpha1E, inhibition identical with that of alpha1B was observed. The differences between alpha1B and alpha1E in the identified region of domain I involve residues that are predicted to be almost exclusively extracellular. Mutations to some of the high-affinity G protein binding regions of alpha1B (alpha interaction domain, CC14, and a C-terminal Galpha binding site) caused relatively little change in inhibition, which suggests that these sites are not necessary individually for G protein-mediated inhibition and may help to explain the small effects of exchanging these regions in isolation.

MeSH Terms
Amino Acid Sequence Binding Sites Calcium Channels/genetics,metabolism,physiology Electrophysiology GTP-Binding Proteins/metabolism Humans Molecular Sequence Data Mutation Protein Structure, Tertiary Receptors, Opioid, kappa/chemistry,metabolism Recombinant Fusion Proteins/metabolism Sequence Homology, Amino Acid
Chemicals
Calcium Channels Receptors, Opioid, kappa Recombinant Fusion Proteins GTP-Binding Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Simen A A
Department of Neurobiology, Pharmacology, and Physiology, and Committee on Neurobiology, The University of Chicago, IL 60637, USA.
Miller R J
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
0026-895X
Published
2000-05-00
Pages
1064-74
Language
English
Region
United States
NLM ID
0035623
Subset
IM
Grants
NIDA NIH HHS · DA02121 · United States
NIMH NIH HHS · MH40165 · United States
NINDS NIH HHS · NS33826 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com